Recall of a Cohort of Subjects in the Mediterranean Area. Monitoring of Liver Diseases (NUTRIHEP 3).
NCT06931925 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2300
Last updated 2025-04-22
Summary
Liver diseases represent a significant public health problem, with a high prevalence and a growing incidence worldwide, and a significant impact on global morbidity and mortality, causing approximately 2 million deaths annually.
Deaths are largely attributable to complications of cirrhosis and hepatocellular carcinoma.
The most common causes of cirrhosis worldwide are related to viral hepatitis, alcohol, and non-alcoholic fatty liver disease caused by poor dietary habits.
Regarding the hepatitis B virus (HBV), the vaccination program, together with the improvement of socioeconomic conditions and greater public awareness, have progressively reduced the incidence and prevalence of this viral disease. Chronic hepatitis related to the hepatitis C virus (HCV), after an increase in the 1980s and 1990s, is showing a decreasing trend, particularly among younger age groups. While other studies have focused on liver diseases of metabolic origin, the most recent epidemiological data concerning the Italian population were collected in the late 1990s. Since a decade has now passed, it was thought that it might be interesting to collect new data on the prevalence pattern of liver diseases, especially in southern Italy, particularly in a municipality equally geographically distant from both the coast and the inland. Therefore, this observational study aims to analyze the evolution of liver diseases through the recall of a cohort of patients already identified in the Mediterranean area. The cohort is composed of individuals residing in the municipality of Putignano (BA) who have already undergone evaluation of liver function, comorbidities and dietary habits, in addition to adding genetic information through genome-wide association (GWAS) analyses, useful for identifying associations between genetic variants and specific phenotypic characteristics
Conditions
- Cohort Study
Sponsors & Collaborators
-
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
lead OTHER
Principal Investigators
-
Rossella Donghia, Biologyst · IRCCS "Saverio de Bellis" - Castellana Grotte (BA) - Italy
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-01
- Primary Completion
- 2026-09-01
- Completion
- 2027-09-01
More Related Trials
-
Prospective Cohort Study of Disease and Outcomes in Cirrhosis
NCT04422223 ·Status: UNKNOWN
-
Effect of Long-term Carvedilol to Prevent Decompensation or Death in Patients With Asymptomatic Child-Pugh A5 to B8 Cirrhosis and Clinically Significant Portal Hypertension: a Multicenter Double-blind Randomized Control Trial
NCT06263816 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Predicting Acute-on-Chronic Liver Failure in Cirrhosis (PREDICT) Study
NCT03056612 ·Status: COMPLETED
-
Study of the Drivers of Late Diagnosis of Alcohol Related Diseases, Alone or in Combination With Metabolic Dysfunconal Associated Fatty Liver Disease, Implementation and Evaluation of Itnerventions to Reduce Its Burden.
NCT06403332 ·Status: RECRUITING ·Phase: NA
-
MRI to Assess the Effect of Non-selective Beta-blocker in Patients With Cirrhosis
NCT03438916 ·Status: COMPLETED
-
Microvesicles and Monocytes to Predict Mortality of Patients with Cirrhosis
NCT03837444 ·Status: COMPLETED
-
Optimized Remission in Alcohol-related Liver Cirrhosis
NCT06866496 ·Status: RECRUITING ·Phase: NA
-
Comparison of Nutritional Screening Tools in Liver Cirrhosis Patients
NCT04502719 ·Status: RECRUITING
-
Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis
NCT06855056 ·Status: RECRUITING
-
Cerebrovascular Reactivity in Hepatic Encephalopathy
NCT01099293 ·Status: COMPLETED
-
Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic Decompensation
NCT02084160 ·Status: COMPLETED
-
Role of Bilirubin Molecular Species in Hepatic Encephalopathy and Acute-on-chronic Liver Failure
NCT05566548 ·Status: UNKNOWN
-
Characterization of Metabolomic Fingerprints in Patients With Acute Liver Failure and Acute-on-chronic Liver Failure With Hepatic Encephalopathy
NCT05772585 ·Status: WITHDRAWN
-
Rôle of the Soluble Endothelial Protein C Receptor in Cirrhosis-associated Hypercoagulability State (EXERCISE)
NCT03625726 ·Status: UNKNOWN ·Phase: NA
-
Portal Vein Thrombosis Relevance on Liver Cirrhosis: Italian Venous Thrombotic Events Registry
NCT01470547 ·Status: COMPLETED
-
Acetyl-L-Carnitine In Severe Hepatic Encephalopathy
NCT01223768 ·Status: COMPLETED ·Phase: NA
-
Decompression Intervention of Variceal Rebleeding Trial (DIVERT)
NCT00006161 ·Status: COMPLETED ·Phase: PHASE3
-
Vienna Vascular Liver Disease Study
NCT03541057 ·Status: RECRUITING
-
4beta-hydroxycholesterol in Cirrhosis
NCT04199910 ·Status: SUSPENDED
-
Infections in Hospitalized Cirrhotic Patients
NCT03137719 ·Status: COMPLETED
-
Phase Angle and Mortality in Patients With Cirrhosis
NCT02023177 ·Status: COMPLETED
-
Telehealth Intervention in Cirrhotics
NCT03969186 ·Status: COMPLETED ·Phase: NA
-
HMB for Denutrition in Patients With Cirrhosis (HEPATIC)
NCT03285217 ·Status: COMPLETED ·Phase: NA
-
Impact of Nutritional Management on the Frailty of Patients Waiting for Liver Transplantation (Via the LFI Tool)
NCT06911619 ·Status: RECRUITING ·Phase: NA
-
Healthcare Utilization in Liver Cirrhosis Patients, a Multicenter Retrospective Cohort Study
NCT06150482 ·Status: RECRUITING